GAPDH and neoplasm: We have shown previously that the glycolytic function of GAPDH in the malignant T cells is not prominent in the end stage of AITL tumor development since inhibition of GAPDH enzymatic activity with its specific inhibitor, kongenic acid, did not prolong survival of our preclinical AITL mice [8].